324 related articles for article (PubMed ID: 29795806)
1. Ameliorative potential of conditioning on ischemia-reperfusion injury in diabetes.
Rehni AK; Dave KR
Cond Med; 2018; 1(3):105-115. PubMed ID: 29795806
[TBL] [Abstract][Full Text] [Related]
2. Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.
Ferdinandy P; Andreadou I; Baxter GF; Bøtker HE; Davidson SM; Dobrev D; Gersh BJ; Heusch G; Lecour S; Ruiz-Meana M; Zuurbier CJ; Hausenloy DJ; Schulz R
Pharmacol Rev; 2023 Jan; 75(1):159-216. PubMed ID: 36753049
[TBL] [Abstract][Full Text] [Related]
3. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
4. Involvement of glycogen synthase kinase-3β in liver ischemic conditioning induced cardioprotection against myocardial ischemia and reperfusion injury in rats.
Yang S; Abbott GW; Gao WD; Liu J; Luo C; Hu Z
J Appl Physiol (1985); 2017 May; 122(5):1095-1105. PubMed ID: 28153944
[TBL] [Abstract][Full Text] [Related]
5. Ischemic conditioning: the challenge of protecting the diabetic heart.
Wider J; Przyklenk K
Cardiovasc Diagn Ther; 2014 Oct; 4(5):383-96. PubMed ID: 25414825
[TBL] [Abstract][Full Text] [Related]
6. Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning.
Ferdinandy P; Hausenloy DJ; Heusch G; Baxter GF; Schulz R
Pharmacol Rev; 2014 Oct; 66(4):1142-74. PubMed ID: 25261534
[TBL] [Abstract][Full Text] [Related]
7. Diabetic Cardiomyopathy and Ischemic Heart Disease: Prevention and Therapy by Exercise and Conditioning.
Crisafulli A; Pagliaro P; Roberto S; Cugusi L; Mercuro G; Lazou A; Beauloye C; Bertrand L; Hausenloy DJ; Aragno M; Penna C
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326182
[TBL] [Abstract][Full Text] [Related]
8. What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets.
Iliodromitis EK; Cohen MV; Dagres N; Andreadou I; Kremastinos DT; Downey JM
J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):357-69. PubMed ID: 25627214
[TBL] [Abstract][Full Text] [Related]
9. Limb remote ischemic per-conditioning in combination with post-conditioning reduces brain damage and promotes neuroglobin expression in the rat brain after ischemic stroke.
Ren C; Wang P; Wang B; Li N; Li W; Zhang C; Jin K; Ji X
Restor Neurol Neurosci; 2015; 33(3):369-79. PubMed ID: 25868435
[TBL] [Abstract][Full Text] [Related]
10. Remote cardiac ischemic conditioning: underlying mechanisms and clinical applications.
Gaspar A; Leite-Moreira AF
Rev Port Cir Cardiotorac Vasc; 2012; 19(4):183-90. PubMed ID: 24490195
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures.
Sanada S; Komuro I; Kitakaze M
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1723-41. PubMed ID: 21856909
[TBL] [Abstract][Full Text] [Related]
12. Signaling mediators modulated by cardioprotective interventions in healthy and diabetic myocardium with ischaemia-reperfusion injury.
Saeid F; Aniseh J; Reza B; Manouchehr VS
Eur J Prev Cardiol; 2018 Sep; 25(14):1463-1481. PubMed ID: 29442529
[TBL] [Abstract][Full Text] [Related]
13. Direct, remote and combined ischemic conditioning in liver surgery.
Stankiewicz R; Grąt M
World J Hepatol; 2021 May; 13(5):533-542. PubMed ID: 34131468
[TBL] [Abstract][Full Text] [Related]
14. Myocardial ischemic conditioning: Physiological aspects and clinical applications in cardiac surgery.
Bousselmi R; Lebbi MA; Ferjani M
J Saudi Heart Assoc; 2014 Apr; 26(2):93-100. PubMed ID: 24719539
[TBL] [Abstract][Full Text] [Related]
15. Remote ischemia conditioning-an endogenous cardioprotective strategy from outside the heart.
Xiong J; Liao X; Xue FS; Yuan YJ; Wang Q; Liu JH
Chin Med J (Engl); 2011 Jul; 124(14):2209-15. PubMed ID: 21933628
[TBL] [Abstract][Full Text] [Related]
16. Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus.
Lejay A; Fang F; John R; Van JA; Barr M; Thaveau F; Chakfe N; Geny B; Scholey JW
J Mol Cell Cardiol; 2016 Feb; 91():11-22. PubMed ID: 26718721
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury.
Sivaraman V; Yellon DM
J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):83-96. PubMed ID: 24038018
[TBL] [Abstract][Full Text] [Related]
18. Preconditioning and postconditioning: underlying mechanisms and clinical application.
Hausenloy DJ; Yellon DM
Atherosclerosis; 2009 Jun; 204(2):334-41. PubMed ID: 19081095
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic potential of ischemic conditioning: an update.
Hausenloy DJ; Yellon DM
Nat Rev Cardiol; 2011 Jun; 8(11):619-29. PubMed ID: 21691310
[TBL] [Abstract][Full Text] [Related]
20. Bradykinin in ischemic conditioning-induced tissue protection: Evidences and possible mechanisms.
Sharma R; Randhawa PK; Singh N; Jaggi AS
Eur J Pharmacol; 2015 Dec; 768():58-70. PubMed ID: 26499976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
